Skip to main content

Table 1 Preoperative information, intraoperative events and PHLF of patients in the training cohort (n = 343), internal validation cohort (n = 171), and external validation cohort (n = 97)

From: An mALBI-Child–Pugh-based nomogram for predicting post-hepatectomy liver failure grade B–C in patients with huge hepatocellular carcinoma: a multi-institutional study

Variables

Training cohort (n = 343)

Internal validation cohort (n = 171)

External validation cohort (n = 97)

Age, years

56 (12.0)

54 (11.5)

51 (13.9)

Sex

Male

298 (86.9)

150 (87.7)

81 (83.5)

Female

45 (13.1)

21 (12.3)

16 (16.5)

Albumin, g/L

40.6 (24.0–53.0)

38.0 (26.5–49.1)

41.2 (25.0–48.7)

Total bilirubin, µmol/L

12.4 (3.1–109.4)

13.6 (5.5–37.2)

12.0 (4.7–51.4)

ALT, U/L

32.4 (5.2–351.0)

31.0 (5.0–144.0)

32.4 (7.2–334.0)

AST, U/L

41.1 (13.0–251.4)

45.0 (14.0–599.0)

38.0 (10.4–308.0)

γ-GT, U/L

102.0 (16.0–1330.0)

94.0 (26.0–969.0)

93.0 (14.0–698.0)

PT, s

12.2 (9.4–19.0)

12.8 (10.9–18.0)

12.0 (10.1–15.2)

INR

1.08 (0.86–1.68)

1.04 (0.86–1.60)

1.07 (0.91–1.34)

Hilar occlusion, min

22 (0–79)

18 (0–96)

25 (0–90)

Intraoperative blood loss, ml

300 (20–4000)

650 (100–8850)

200 (20–2500)

Extent of resection

Major

308 (89.8)

158 (92.3)

87 (89.7)

Minor

35 (10.2)

13 (7.6)

10 (10.3)

Type of hepatectomy

Laparoscopic

5 (1.5)

2 (1.1)

0 (0)

Open

338 (98.5)

169 (98.8)

97 (100.0)

Cirrhosis

Yes

250 (72.9)

115 (67.3)

86 (88.7)

No

93 (27.1)

56 (32.7)

11 (11.3)

HBsAg

Positive

241 (70.3)

127 (74.3)

75 (77.3)

Negative

102 (29.7)

44 (25.7)

22 (22.7)

HBeAg

Positive

48 (14.0)

29 (17.0)

11 (11.3)

Negative

295 (86.0)

142 (83.0)

86 (88.7)

HBV DNA

Positive

213 (62.1)

104 (60.8)

65 (67.0)

Negative

130 (37.9)

67 (39.2)

32 (33.0)

No. of tumors

Single

191 (55.7)

103 (60.2)

66 (68.0)

Multiple

152 (44.3)

68 (39.8)

31 (32.0)

BCLC stage

A

151 (44.0)

59 (34.5)

44 (45.4)

B

74 (21.6)

28 (16.4)

19 (19.6)

C

118 (34.4)

84 (49.1)

34 (35.1)

AFP, ng/mL

 < 20

118 (34.4)

53 (31.0)

29 (29.9)

20–400

76 (22.2)

41 (24.0)

17 (17.5)

 > 400

149 (43.3)

77 (45.0)

51 (52.6)

mALBI grade

1

233 (67.9)

120 (70.2)

36 (37.1)

2a

75 (21.9)

41 (24.0)

40 (41.2)

2b

35 (10.2)

10 (5.8)

21 (21.6)

Child–Pugh scores

A

327 (95.3)

166 (97.1)

91 (93.8)

B

16 (4.7)

5 (2.9)

6 (6.2)

PHLF, grade B–C

Yes

52 (15.2)

22 (12.9)

23 (23.7)

No

291 (84.8)

149 (87.1)

74 (76.3)

  1. Categorical variables are summarized as n (%). Continuous variables are summarized as median (range) or mean (standard deviation), as appropriate. Pearson χ2, Fisher’s exact, and Mann–Whitney U (Wilcoxon rank sum test) tests were used, as appropriate
  2. AFP α-fetoprotein, mALBI Modified albumin-bilirubin, ALT Alanine aminotransferase, AST Aspartate transaminase, γ-GT gamma-glutamyl transferase, PT Prothrombin time, INR International normalized ratio, PHLF Post-hepatectomy liver failure